Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury
Phase 4
Recruiting
- Conditions
- Radiotherapy Side EffectRadiotherapy; ComplicationsCervical Cancer
- Interventions
- Drug: KANG FU PEN
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 520
- Registration Number
- NCT04819685
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Perioperative Cardiac Complications in Noncardiac Surgery in Tibet, China
- Conditions
- Perioperative Cardiac Complications
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 700
- Registration Number
- NCT04819698
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, China
Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- AnlotinibAnti-PD-1 AntibodyAdvanced Pancreatic Cancer
- Interventions
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT04803851
- Locations
- 🇨🇳
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617
Early Phase 1
- Conditions
- Adenoid Cystic Carcinoma
- Interventions
- Drug: 1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2021-03-23
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04801264
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer
Phase 2
- Conditions
- SHR-1210AnlotinibAdvanced Esophageal Squamous Cell Cancer
- Interventions
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2021-03-15
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT04797507
68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients
- First Posted Date
- 2021-03-12
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT04796467
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Cohort Study of Endometriosis at Different Sites
Completed
- Conditions
- Recruitment
- Interventions
- Procedure: Surgical endometrioma excision
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 146
- Registration Number
- NCT04783623
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Online Survey of Nutrition Status in Chinese Non-hospitalized Cancer Patients
Completed
- Conditions
- Cancer PatientNutrition StatusSurvey
- First Posted Date
- 2021-03-03
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 6685
- Registration Number
- NCT04778540
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Establishing Malnutrition Diagnosis System by Using Artificial-intelligence Technology
Completed
- Conditions
- Disease-related Malnutrition
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04776070
- Locations
- 🇨🇳
Dongcheng district，Peking union medical college hospital, Beijing, Beijing, China
Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer
- Conditions
- Advanced Colorectal Carcinoma
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT04771715
- Locations
- 🇨🇳
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath